Insight on ready-to-go spheroids and media for drug discovery 

More physiologically and pathologically relevant preclinical human liver models are needed for drug liver liability assessment and liver disease modeling. This app note offers insight and media for drug discovery. 

While Drug-Induced Liver Injury (DILI) remains a major safety concern, several recent high-profile NAFLD/NASH clinical trial failures further highlight this critically unmet need. With the advances in 3D culture, we and others have demonstrated the usefulness of liver spheroids made from primary human hepatocytes (PHHs) as a novel tool for in vitro hepatotoxicity studies.  

Co-cultures of liver spheroids made from human liver cells may be a useful model to better understand the roles of different non-parenchymal cells and cell-cell interactions under physiological and pathological conditions. 

Download this Corning app note to learn more here. 

Related Articles

Join FREE today and become a member
of Drug Discovery World

Membership includes:

  • Full access to the website including free and gated premium content in news, articles, business, regulatory, cancer research, intelligence and more.
  • Unlimited App access: current and archived digital issues of DDW magazine with search functionality, special in App only content and links to the latest industry news and information.
  • Weekly e-newsletter, a round-up of the most interesting and pertinent industry news and developments.
  • Whitepapers, eBooks and information from trusted third parties.
Join For Free